Search all trials

Find therapies in clinical trials near you – page 21

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Chronic graft versus host disease

Not recruiting

Registered drug

Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Alectinib and Durvalumab for Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Alectinib

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study Comparing Standard Chemotherapy with CPX-351 for Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) and Intermediate or Adverse Genetics

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Hypertension

Not recruiting

Investigational

Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Baxdrostat

Contact Research Centre

Bladder cancer

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Skin ulcer

Not recruiting

Investigational

Study on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drug

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Chronic cutaneous lupus erythematosus+2

Not recruiting

Investigational

Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Litifilimab

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drug

Study of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Mrna-4157

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Find therapies in clinical trials near you – page 21

315 trials match your criteria

Chronic graft versus host disease

Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

Non-small cell lung cancer

Study on Alectinib and Durvalumab for Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer

Acute myeloid leukaemia

Study Comparing Standard Chemotherapy with CPX-351 for Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) and Intermediate or Adverse Genetics

Hypertension

Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Bladder cancer

Study on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer

Non-small cell lung cancer

Study on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer

Skin ulcer

Study on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds

Malignant melanoma

Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma

Hormone receptor positive HER2 negative breast cancer

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Chronic cutaneous lupus erythematosus+2

Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Transitional cell carcinoma

Study of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery

Bladder transitional cell carcinoma

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.